Caribou Biosciences Files 8-K on Shareholder Votes & Financials
Ticker: CRBU · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1619856
| Field | Detail |
|---|---|
| Company | Caribou Biosciences, INC. (CRBU) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financials, filing
Related Tickers: CRBU
TL;DR
CRBU filed an 8-K for shareholder votes and financials - details to come.
AI Summary
On June 12, 2025, Caribou Biosciences, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The filing does not disclose specific details about the matters to be voted on or the financial results themselves, but indicates these items are being formally presented.
Why It Matters
This filing signals that Caribou Biosciences is proceeding with important corporate actions requiring shareholder approval and is formally presenting its financial status, which could impact investor decisions.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new material financial or operational information that would immediately impact risk.
Key Numbers
- 001-40631 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-3728228 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Caribou Biosciences, Inc. (company) — Registrant
- June 12, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- Berkeley, California (location) — Principal Executive Offices
FAQ
What specific matters are being submitted to a vote of Caribou Biosciences' security holders?
The filing indicates that matters are being submitted to a vote of security holders, but does not specify what those matters are.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on June 12, 2025.
What is Caribou Biosciences' principal executive office address?
Caribou Biosciences' principal executive office is located at 2929 7th Street, Suite 105, Berkeley, California 94710.
What is the company's state of incorporation?
Caribou Biosciences, Inc. is incorporated in Delaware.
Does this 8-K filing contain specific financial statement details?
The filing states that financial statements are included, but the provided text does not detail the specific financial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Caribou Biosciences, Inc. (CRBU).